Search results
Hanmi Enters into Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BH3120 in...
NBC 17 Raleigh· 7 days agoUpon the execution of the agreement, Hanmi Pharmaceutical will conduct a phase 1 clinical trial to evaluate the safety and efficacy of its immuno-oncology drug, 'BH3120', in combination with ...
NHS trials first personal skin cancer jab that can halve risk of death
The Telegraph via Yahoo News· 4 days agoIt is also undergoing early testing on other cancers. Around 70 Britons are set to take part in a...
U.K. Tests World-First Personalized Skin Cancer Vaccine
Forbes· 4 days agoBritish patients are trying a first-of-its-kind customized vaccine for skin cancer as part of a...
ESMO Recap: Adjuvant Vs. Neoadjuvant Therapy in Melanoma
Medscape· 5 days agoSapna Patel presented the first abstract, and it was a follow-up on some very nice work from the...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 5 days agoPhase 2/3 pivotal trial design and protocol for HB-200 in combination with pembrolizumab for the first-line treatment of patients with HPV16+ recurrent or metastatic OPSCC ...
HOOKIPA advances HPV cancer trial with FDA nod By Investing.com
Investing.com· 5 days agoHOOKIPA Pharma Inc. (NASDAQ: HOOK), a clinical-stage biopharmaceutical company, has announced the...
H.C. Wainwright Cuts HOOKIPA Pharma Shares target on Narrower HB-200 Target Population By...
Investing.com· 4 days agoThe adjustment followed HOOKIPA Pharma's announcement regarding the trial design of a Phase 2/3...
Immutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort B
Morningstar· 6 days agoMedia Release Data from efti in combination with KEYTRUDA® in first line head and neck squamous cell carcinoma patients who do not express PD-L1 (TACTI-003, Cohort B) shows a preliminary 26.9% response rate, the primary endpoint of the studyData
British man tests first personalised melanoma vaccine
BBC via Yahoo News· 5 days agoUniversity College London Hospitals (UCLH) doctors are giving it alongside another drug, ...
Moderna cancer vaccine offers long-term hope in melanoma
Proactive Investors· 4 days agoCovid vaccine maker Moderna Inc and partner Merck Sharp and Dohme (MSD) have initiated a phase III...